Ulf Wiinberg

Ulf Wiinberg is a declared insider of Hansa Biopharma AB, with filings sourced from Finansinspektionen. In total, 4 filings cover trades dated from 21 May 2019 to 16 July 2021.

Every open-market trade on record is a purchase: 4 purchases worth €542k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2021 alone, the filings show 1 purchase and no sales.

The median purchase comes to €136k. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 19 July 2021, the filings show an open-market purchase worth €110k in Hansa Biopharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.